alexa An Unusual Case of Grave’s Disease with Primary Sclerosing Cholangitis (PSC) | Open Access Journals
ISSN: 2165-7920
Journal of Clinical Case Reports
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

An Unusual Case of Grave’s Disease with Primary Sclerosing Cholangitis (PSC)

Abdul-Rahman Mashi1* and Naji J Al-Johani2

1Department of Internal Medicine, King Fahad Medical City, Saudi Arabia

2Endocrine and Metabolic Center, King Fahad Medical City, Saudi Arabia

*Corresponding Author:
Abdul-Rahman Mashi
Department of Internal Medicine
King Fahad Medical City, Saudi Arabia
Tel: +966112889999
E-mail: ahmashi@kfmc.med.sa

Received Date: December 03, 2016; Accepted Date: January 22, 2017; Published Date: January 27, 2017

Citation: Mashi AR, Al-Johani NJ (2017) An Unusual Case of Grave’s Disease with Primary Sclerosing Cholangitis (PSC). J Clin Case Rep 7: 916. doi: 10.4172/2165-7920.1000916

Copyright: © 2017 Mashi AR, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Clinical Case Reports

Abstract

Grave’s disease is an autoimmune thyroid disease with multi-system involvement. It’s manifestations are diverse, including liver function abnormalities and association with other autoimmune disease. The objective of this report is to present an unusual case of Grave’s disease with PSC. This is a 28-year-old woman that present with cholestatic jaundice along with signs and symptoms of thyrotoxicosis. She diagnosed to have Grave’s disease with PSC. Despite an initial high bilirubin, treatment with antithyroid agents in addition to Ursodeoxycholic acid led to marked improvement in her clinical status and bilirubin level. The proposed mechanisms underlying the association of Grave’s disease with PSC are discussed and the literature on similar cases is highlighted. Both Grave’s disease and PSC have been shown to be associated with other autoimmune mediated diseases. This case report shows an association between Grave’s disease and PSC whether due to an underlying immune-genetic predisposition or coincidence. Further studies are needed to investigate this association.

Keywords

Grave’s disease; Primary sclerosing cholangitis (PSC); Immunogenetic mechanism; Association between Grave’s and PSC

Introduction

Primary sclerosing cholangitis (PSC) is a cholestatic liver disease of unknown etiology characterized by inflammation and destruction of both the intra- and extrahepatic bile ducts progressing to fibrosis and ultimately cirrhosis [1]. Acceptable mechanisms include immunological and genetics factors [2]. Grave’s disease is an autoimmune disease of the thyroid gland which affects approximately 0.5% of the population and is the underlying cause of 50% to 80% of hyperthyroidism cases [3]. While rare, Grave’s disease may be associated with other liver conditions and autoimmune disorders [4]. Few cases have reported Grave’s disease with PSC. The present case aims to shed light in this gap.

Case Report

A 28-year-old Saudi female was presented in the emergency department of King Fahad Medical City (KFMC), Riyadh, Saudi Arabia, with a history of chronic pruritus (4 months) with undocumented weight loss, diarrhea, palpitations and heat intolerance in the last month. Five days prior to presentation she developed jaundice. Grave’s disease was present in the family history (maternal).

On examination, the patient had icteric sclera with a pulse rate of 100 beats/min. Physical examination showed signs of thyrotoxicosis. She had a diffusely enlarged thyroid gland with positive bruit, hand tremors, warmth, and sweating. Eyes signs: lid lag, lid retraction and exophthalmos with evidence of proximal myopathy. Laboratory showed elevated liver function: ALT: 128 IU/L, AST: 78 IU/L, ALP: 364 IU/L, GGT: 251 mg/dl, Total bilirubin 110.4 mg/dl and direct bilirubin: 95.9 mg/dl. Thyroid function test was consistent for hyperthyroidism (TSH<0.005 ml U/L, Free T4: 88.4 pmol/l, Free T3: 36.4 pmol/l, positive TSH receptors antibodies, Anti-TPO 225.6 and TG 5.35) (Tables 1 and 2). Thyroid ultrasound showed diffusely enlarged thyroid gland (The right lobe is measuring 1.8 cm × 2.1 cm × 5.3 cm and the left 1.9 cm × 1.7 cm × 4.9 cm) with heterogeneous echotexture and increased vascularity. Thyroid scintigraphy showed enlarged thyroid with diffusely inhomogeneous increased uptake consistent with the diagnosis of Grave’s disease (Figures 1 and 2). Computerized tomography (CT) of the abdomen and pelvis with IV contrast in the porto-venous phase showed irregularly dilated intrahepatic biliary tree suggestive of PSC. Magnetic resonance cholangiopancreatography (MRCP) showed biliary abnormalities consistent with PSC (Figure 3). Liver biopsy confirmed PSC diagnosis (Figure 2). The patient was initially started on propranolol 40 mg orally TID to control thyrotoxic symptoms, after which she was given Carbimazole 10 mg orally daily. Also, she was started on ursodeoxycholic acid 500 mg orally BID. After improvement of thyroid function with anti-thyroid medications, she underwent radioactive iodine treatment of the thyroid gland which subsequently led to marked improvement in her follow-up liver function tests. With time her liver function worsened again with impairment of synthetic function, so she is referred to a liver transplant center and currently she is waiting to undergo liver transplantation.

Laboratory data Result
Liver function test
AST (IU/L) 78
ALT (IU/L) 128
Total bilirubin (mg/dL) 110.4
Direct bilirubin (mg/dL) 95.9
GGT (IU/L) 251
ALP (IU/L) 364
Albumin (g/L) 37
INR 1.8
Viral markers
IgM anti-HAV  
HBsAg  Negative
Anti-HBc Negative
  Anti-HBs Negative
Anti-HCV Negative
Thyroid function test
TSH(mlU/l) <0.005
Free T4(pmol/l) 88.4
Free T3 (pmol/l) 36.4
Autoantibodies
Thyroid stimulating antibody Positive
Anti-TPO 225.6
TG 5.35
Anti-LKM Negative
ANA 1:40
Anti-smooth muscle antibody Negative
AMA  

Table 1: Laboratory data on admission.

Laboratory data Sep 2012 Jan 2013 May 2013
Liver function test
ALT (IU/L) 128 51 69
Total bilirubin (mg/dL) 110.4 298.2 44.3
Direct bilirubin (mg/dL) 95.9 272 35.5
GGT (IU/L) 251 - 522
ALP (IU/L) 364 203 313
Thyroid function test
TSH (mlU/l) 0.005 0.005 0.005
Free T4 (pmol/l) 88.4 31.2 14.6
Free T3 (pmol/l) 36.4 9 4

Table 2: Follow up liver and thyroid function tests.

clinical-case-reports-Thyroid-scintigraphy

Figure 1: Thyroid scintigraphy showed enlarged thyroid with diffusely inhomogeneous increased uptake.

clinical-case-reports-Bile-duct

Figure 2: Bile duct disease consistent with sclerosing cholangitis with early cirrhosis.

clinical-case-reports-extrahepatic-biliary

Figure 3: MRCP and liver showed irregularity of the intra and extrahepatic biliary channels consistent with PSC.

Discussion

The exact etiology of PSC remains unknown, but several proposed mechanisms include immunologic, infectious, toxic and genetic mechanisms [2]. Majority of existing studies agree that immunogenetic process is the most acceptable pathologic mechanism for PSC based on its association with HLA-B8, DR [3], DR2, DR [4,5-8] and DRw52a [9] as well as increased risk of PSC and ulcerative colitis in first-degree relatives of patients with PSC [10] common association with ulcerative colitis and less commonly with other autoimmune diseases like rheumatoid arthritis, SLE, systemic sclerosis and autoimmune hepatitis [11,12] HLA-B8 and DR3 are associated with autoimmune diseases such as Graves’ disease, systemic lupus erythematosus, and myasthenia gravis [13]. The clinical manifestations of hyperthyroidism are largely diverse, including liver function abnormalities [14-16]. The liver has a central role in de-iodination and also performs specific functions related to thyroid hormone transport and metabolism [17-20]. Normal functioning thyroid and liver axis are essential for normal growth and metabolism [21]. PSC in comparison with inflammatory bowel disease (IBD) was found to be more common with other autoimmune diseases like Hashimoto’s thyroiditis, Graves’s disease and Riedel’s thyroiditis [2]. Furthermore, hyperthyroidism is associated with liver function abnormalities, including elevations in transaminases, alkaline phosphatase, prothrombin activity, bilirubin and low serum albumin, although the mechanism of liver dysfunction is unclear [15]. The incidence of thyroid disease with PSC is 2.1 per 100 person-years [16]. In another study looked for associated immune-mediated diseases in 241 patients with primary sclerosing cholangitis, 4% of patients have an association with thyroid disease [22]. Improvement in bilirubin and thyroid function tests seems to be parallel with hyperthyroidism being the crucial contributing factor to cholestasis [15].

Conclusion

This case report showed an association between Grave’s disease and PSC whether due to an underlying immune-genetic predisposition or coincidence. Further studies are needed to investigate this association.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Article Usage

  • Total views: 96
  • [From(publication date):
    January-2017 - Mar 28, 2017]
  • Breakdown by view type
  • HTML page views : 76
  • PDF downloads :20
 
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

OMICS International Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
OMICS International Conferences 2016-17
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsonline.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsonline.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsonline.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsonline.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsonline.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsonline.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsonline.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsonline.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsonline.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsonline.com

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

materialsci@omicsonline.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsonline.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsonline.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsonline.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsonline.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsonline.com

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version